One shot at H1N1


967 [economic] environment like this one, you can’t tell what they will do.” Osiris continues undaunted. On September 30, researchers at the University of California, San Francisco announced they were enrolling patients in a phase 2 study of Prochymal in first-time heart attacks. The university plans to enroll just 10 patients, but a total of about 220 are… (More)
DOI: 10.1038/nbt1109-967a


Cite this paper

@article{Wolfson2009OneSA, title={One shot at H1N1}, author={Wendy Wolfson}, journal={Nature Biotechnology}, year={2009}, volume={27}, pages={967-967} }